REFERENCES
- Freeman S, Shulman LP. Considerations for the use of progestin only contraceptives. J Am Acad Nurse Practitioner 2010;22:81–91.
- Hickey M, Salamonsen LA. Endometrial structural and inflammatory changes with exogenous progestins. Trends Endocrinol Metab 2008;19:167–74.
- Trussell J. Contraceptive efficacy. In Hutcher RA, Trussell J, Stewart FH, . (Eds), Contraceptive technology, 18th edn. New York: Ardent Media 2004: 773–845.
- Balogun OR. Analysis of weight, packed cell volume changes, and menstrual pattern in Norplant acceptors in Ilorin, Nigeria. Niger J Clin Pract 2007;10:116–9.
- International Collaborative Post-Marketing Surveillance of Norplant. Post-marketing surveillance of Norplant® contraceptive implants: I. Contraceptive efficacy and reproductive health. Contraception 2001;63: 167–86.
- Graeslin O, Korver T. The contraceptive efficacy of Implanon®: A review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care 2008;13(Suppl. 1):4–12.
- Zheng SR, Zheng HM, Qian SZ, . A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant. Contraception 1999;60:1–8.
- Kiriwat O, Patanayindee A, Koetsawang S, . A 4-year pilot study on the efficacy and safety of Implanon®, a single-rod hormonal contraceptive implant, in healthy women in Thailand. Eur J Contracept Reprod Health Care 1998;3:85–91.
- Funk S, Miller MM, Mishell DR Jr, . The Implanon US study group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319–26.
- Barbosa IC, Maia H JR, Coutinho E, . Effects of a single Silastic® contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year. Contraception 2006;74:492–7.
- Brache V, Faundes A, Alvarez F, Cochon L. Nonmenstrual adverse events during use of implantable contraceptives for women: Data from clinical trials. Contraception 2002;65:63–74.
- Hickey M, Fraser IS. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel implants. Implications for the mechanisms of breakthrough bleeding. Hum Reprod 2002;17:2428–34.
- Hickey M, Krikun G, Kodaman P, . Long-term progestin-only contraceptives result in reduced endometrial blood flow and oxidative stress. J Clin Endocrinol Metab 2006;91:3633–8.
- Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. The effects of Implanon® on menstrual bleeding patterns.Eur J Contracept Reprod Health Care 2008;13(Suppl. 1):13–28.
- Varma R, Mascarenhas L. Endometrial effects of etonogestrel (Implanon) contraceptive implant. Curr Opin Obstet Gynecol 2001;13:335–41.
- Van den Bosch T, Donders GGG , Riphagen I, . Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant. Ultrasound Obstet Gynecol 2002;20:377–80.